Medication for addiction treatment and acute care utilization in HIV-positive adults with substance use disorders.
Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME, USA.
Tufts University School of Medicine, Boston, MA, USA.
Boston Medical Center, Boston, MA, USA.
Boston University School of Medicine, Boston, MA, USA.
Boston University School of Public Health, Boston, MA, USA.
Center for Healthcare Organization and Implementation Research, ENRM Memorial VA Hospital, Bedford, MA, USA.
Clinical Research and Education Unit, Section of General Internal Medicine, Boston, MA, USA.
- Published Article
- Publication Date
Sep 01, 2020
Medication for addiction treatment (MAT) could reduce acute care utilization in HIV-positive individuals with substance use disorders. The study objective was to determine if HIV-positive people with substance use disorders treated with MAT report less acute care utilization than those not receiving MAT. We assessed the association between MAT and acute care utilization among HIV-positive individuals with alcohol or opioid use disorder. Acute care utilization 6 months later was defined as any past 3-month self-reported (1) emergency department (ED) visit and (2) hospitalization. Of 153 participants, 88% had alcohol use disorder, 41% had opioid use disorder, and 48 (31%) were treated with MAT. Fifty-five (36%) participants had an ED visit and 38 (25%) participants had a hospitalization. MAT was not associated with an ED visit (AOR 1.12, 95% CI 0.46-2.75) or hospitalization (AOR 1.09, 95% CI 0.39-3.04). MAT was not associated with acute care utilization. These results highlight the need to increase MAT prescribing in HIV-positive individuals with substance use disorders, and to address the many factors that influence acute care utilization.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 09/23/2020 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/31686528